RALEIGH – Plant Health Care, an agtech startup developing patent-protected biological products to global agriculture markets, has raised around $3.02 million in equity, according to a recent SEC filing.
The Raleigh-based company confirmed that it received the funds from Ospraie Ag Science LLC in a release.
OAS is the venture capital arm of Ospraie Management, LLC (“Ospraie”), the New York based investment management firm, which specializes in investing in commodities, agriculture and other basic industries on a global basis.
“We are delighted to have OAS join our investor community, making funds available to accelerate our plans to generate further growth and shareholder value,” said Plant Health Care CEO Chris Richards, in a statement.
“Their investment will enable PHC to build upon the growth and profitability of our commercial business and continue the momentum of the commercialization of our exciting PREtec products.”
Plant Health Care develops technologies that protect crops from diseases and environmental stresses, according to its website.
The end goal: to increase crop yield and quality.
Among its core technologies is PREtec (Plant Response Elicitor technology).
“Based on our unique understanding of how key amino acid sequences elicit a desired response in target crops, we are able to design families of peptides (chains of amino acids) that when applied to crops provide increased growth, disease resistance and other benefits for farmers,” it says on its website.
The startups has designed and filed patent applications for four peptide platforms from our research; three of these have been named and all four have been launched with partners.
Each family of related peptides is considered its own platform, all covered by extensive patent filings.
